'NanoJacket' shows potential for cancer treatment
Researchers at Penn State College of Medicine are working on a new nanotechnology drug delivery system to treat breast cancer. The "NanoJacket" particle targets a gene mutation that causes overexpression of an oncogenic protein in breast cancer patients with poor outcomes and delivers an RNA segment that kills cancer cells.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063